Offered in TO-263 (D²PAK) Package, Device Combines High Pulse Absorption to 15 J/0.1 s With Power Dissipation of 35 WMALVERN, Pa., May 14, 2025 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today announced that it has extended its D2TO35 series of surface-mount thick film power resistors with a new AEC-Q200 qualified device that delivers higher pulse absorption up to 15 J/0.1 s. Offered in the TO-263 (D²PAK) package, the Vishay Sfernice D2TO35H provides high power dissipation of 35 W at a +25 ...

Core Viewpoint - Beam Global, a provider of sustainable infrastructure solutions for electrification and energy security, will report its Q1 2025 operating results on May 15, 2025, after market close, followed by a conference call to discuss the results and corporate developments [1]. Group 1: Conference Call Details - The conference call is scheduled for May 15, 2025, at 4:30 p.m. Eastern / 1:30 p.m. Pacific [2]. - Callers are required to pre-register for the call through a provided link and should dial in approximately 10 minutes before the scheduled start time [2]. Group 2: Company Overview - Beam Global is a clean technology innovator focused on sustainable energy infrastructure, EV charging solutions, energy storage, and energy security [4]. - The company operates in the U.S. and Europe, developing and manufacturing advanced clean technology solutions [4]. - Beam Global is headquartered in San Diego, CA, with additional facilities in Broadview, IL, and Serbia [4].

FORT LAUDERDALE, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB US: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) today announced the Company’s consolidated financial results for the fiscal quarter that ended March 31, 2025 (“fiscal quarter 3”). Zefiro also today announced that it has received a Notice of Failure to Pay in connection with a $2 million promissory note ("Note"), created in conjunction with the May 12, 2023, acquisition of Plants and Goodw ...

NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW CALGARY, Alberta, May 14, 2025 (GLOBE NEWSWIRE) -- Alaris Equity Partners Income Trust (“Alaris” or the “Trust”) (TSX: AD.UN) is pleased to announce that as a result of excess demand, it has agreed with the syndicate of underwriters led by National Bank Financial Inc., CIBC Capital Markets, and Desjardins Capital Markets to increase the size of its previously announce ...

Group 1 - American Airlines Group Inc. will have its Chief Financial Officer, Devon May, present at the 2025 Wolfe Research Global Transportation & Industrials Conference on May 22 at 11:15 a.m. CT [1] - A live webcast of the conference will be available on the company's investor relations website [1] Group 2 - American Airlines is a leading global airline, operating thousands of flights daily to over 350 destinations in more than 60 countries [2] - The airline is a founding member of the oneworld® alliance, which collectively serves over 900 destinations worldwide [2] - Shares of American Airlines Group Inc. are traded on Nasdaq under the ticker symbol AAL [2]

Core Viewpoint - Super League Enterprise, Inc. has successfully completed a public offering of common stock, with the underwriter exercising an option to purchase additional shares, resulting in increased gross proceeds for the company [1]. Group 1: Offering Details - The underwriter purchased an additional 617,647 shares at a public offering price of $0.17 per share, leading to approximately $105,000 in additional gross proceeds [1]. - The total number of common stock sold in the offering increased to 5,735,294 shares, with total gross proceeds reaching approximately $974,999 before deducting underwriting fees and other estimated expenses [1]. - The exercise of the over-allotment option is expected to close on May 14, 2025, subject to customary closing conditions [1]. Group 2: Company Background - Super League Enterprise, Inc. is a leader in redefining brand-consumer connections through playable media, providing global brands with ads, content, and experiences integrated within mobile games and immersive gaming platforms [5]. - The company utilizes proprietary technology and an award-winning development studio to create impactful brand experiences that resonate with consumers [5].

America’s Diner unveils delicious new Summer-inspired menu line-up – while doubling down on value! Denny's Limited Time Summer Menu Denny's launches the Red, White and Berry Pancake Slam for a limited time this summer. Denny's Limited Time Summer Menu Denny's launches the Bacon Ranch Cheeseburger and Strawberry Sparkler beverage for a limited time this summer. Spartanburg, SC, May 14, 2025 (GLOBE NEWSWIRE) -- Summer is right around the corner, and Denny’s is ready with new fresh dishes bursting with ...

RYE, N.Y., May 14, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of The Gabelli Equity Trust Inc. (NYSE:GAB) (the “Fund”) reaffirmed and satisfied its 10% distribution policy by declaring a $0.15 per share cash distribution payable on June 23, 2025 to common stock shareholders of record on June 13, 2025. The Fund intends to pay a minimum annual distribution of 10% of the average net asset value of the Fund within a calendar year or an amount sufficient to satisfy the minimum distribution requirements of t ...

Core Insights - Genmab is presenting 14 abstracts on epcoritamab at the 30th European Hematology Association Congress, showcasing its development across various patient populations and treatment settings [1][4] - Epcoritamab is a T-cell engaging bispecific antibody designed for treating diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) [6][7] Development Program - The abstracts include data from Phase 1/2 trials evaluating epcoritamab in combination with other therapies for relapsed/refractory DLBCL and previously untreated DLBCL [2][4] - Key trials include EPCORE NHL-2 and NHL-5, focusing on combinations with rituximab and polatuzumab vedotin [2][5] Presentation Details - Oral presentations will occur on June 15, 2025, featuring significant findings from the EPCORE NHL-2 and NHL-5 trials [5] - Additional results from NHL-1 and NHL-3 trials will be presented as posters, highlighting three years of follow-up data [2][5] Regulatory Status - Epcoritamab has received regulatory approval in specific lymphoma indications in the U.S., Japan, and the EU, and is co-developed with AbbVie [7][10] - The companies are pursuing further international regulatory approvals for additional indications [7] Future Directions - Genmab and AbbVie are conducting five ongoing Phase 3 trials to evaluate epcoritamab's efficacy as a monotherapy and in combination therapies across various hematologic malignancies [8][9] - The companies aim to establish epcoritamab as a core therapy for B-cell malignancies [4][8]

Core Viewpoint - MicroAlgo Inc. has announced the development of the Quantum Information Recursive Optimization (QIRO) algorithm, which aims to enhance combinatorial optimization problems by utilizing quantum computing capabilities [1][7]. Group 1: Algorithm Overview - The QIRO algorithm is designed to tackle complex combinatorial optimization problems by integrating quantum computing and recursive algorithms, leveraging parallel computing and quantum state properties [1][7]. - The algorithm recursively invokes quantum optimization processes, progressively reducing problem size to find optimal solutions [4][7]. Group 2: Technical Process - The first step involves modeling the combinatorial optimization problem by defining the objective function, constraints, and candidate elements [2]. - Quantum states are initialized through quantum gate operations, allowing for simultaneous processing of multiple computational paths [3]. - Quantum measurement is performed at the recursion's boundary conditions to extract optimal or near-optimal solutions [5]. - The extracted solution is verified and optimized by comparing objective function values to identify the best solution [6]. Group 3: Advantages and Applications - The QIRO algorithm demonstrates significant technical advantages, achieving exponential improvements in computational efficiency and stronger global search capabilities compared to traditional algorithms [7]. - It is flexible and can be tailored to meet specific problem requirements, enhancing its effectiveness across various applications [7]. - The algorithm has practical applications in logistics, resource allocation, network planning, and graph theory-related problems, proving its value in real-world scenarios [8]. Group 4: Future Potential - The QIRO algorithm holds immense growth potential as quantum technology advances, improving the quality and accessibility of quantum resources [9][10]. - It may serve as a model for developing additional hybrid quantum-classical algorithms, expanding quantum computing applications across various industries [10]. Group 5: Company Background - MicroAlgo Inc. is dedicated to developing and applying bespoke central processing algorithms, providing comprehensive solutions that enhance customer satisfaction and achieve technical goals [11].